Optimize Anticoagulants to Reduce Stroke Risk in Atrial Fib Patients

March 2019

There will be buzz about optimizing anticoagulant use in atrial fib patients...based on the latest Am Heart Association and Chest guidelines.

Use these strategies to balance risks and benefits.

Identify stroke risk factors in atrial fib using the "CHA₂DS₂-VASc" score...ongestive heart failure, Hypertension, Age 75 and up, Diabetes, prior Stroke or TIA, Vascular disease (heart attack or peripheral artery disease), Age 65 to 74, or Sex category (female).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Stroke Limit Dual Antiplatelet Therapy After a Stroke or TIA to Short-Term Use
Geriatrics Consider the New Beers Criteria When Prescribing Meds for Older Adults
Diabetes Keep Heart Failure in Mind When Prescribing Meds for Diabetes
Muscle Relaxants Use Muscle Relaxants With Caution
Respiratory & Allergy Help Guide Safe Use of Neti Pots and Nasal Irrigation
Anticoagulants Optimize Anticoagulants to Reduce Stroke Risk in Atrial Fib Patients
Acne Don't Buy the Hype About New Acne Meds Altreno and Seysara
Generics Be Ready for New Albuterol HFA and Advair Diskus Generics
Tuberculosis Focus on Safety and Adherence With Antibiotics for Latent TB
Epinephrine Be Aware of Differences Between Symjepi and Epinephrine Auto-Injectors
Diabetes Have a Plan to Manage Diabetes Meds Before and After Surgery
Opioids Explain the Controversy About the New Sublingual Sufentanil (Dsuvia)

Optimize Anticoagulants to Reduce Stroke Risk in Atrial Fib Patients

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents